If you are an investor who wants to invest his or her money in safer stocks, cannabis stocks might offer a great opportunity. With Covid-19 vaccines being rolled out this year, people will be resorting to normalcy and the use of cannabis will surge.
Cannabis stocks are popular and if you are looking to invest in them, here are 3 top cannabis stocks that might be a great consideration.
Aurora Cannabis Inc. (NYSE: ACB)
Aurora Cannabis Inc. (NYSE: ACB) is a popular cannabis company offering a chance for investors to make good money off of their investments. With its stock priced at $10.52 today, Aurora Cannabis stock met some serious highs and lows in the last one year. However, since 2021, its stock has performed considerably well.
Based in Edmonton, Canada, Aurora Cannabis (NYSE: ACB) not only produces but distributes and sells many cannabis products. Their management has also hinted towards expansion which means that they will have more to sell and this will mean even higher revenues. Aurora Cannabis is a household name in the cannabis industry. If you are looking for Cannabis IPO stocks, Aurora Cannabis already had one and it would be a good opportunity to invest in the company’s stock this year.
Aphria Inc. (NASDAQ: APHA)
Aphria Inc. (NASDAQ: APHA) is also a great investment if we are talking about cannabis stocks. The company produces and sells medical cannabis directly to registered patients throughout Canada. One reason to invest in Aphria Inc. (NASDAQ: APHA) is that it offers a wide variety of cannabis products and strains including sativa, hybrid and indica.
Aphria Inc. is the first Canadian LP that utilizes greenhouses. It is the lowest cost producer of cannabis in the Canadian cannabis industry which is why its revenues continue to grow. Aphria stock is in high demand and will make for a good investment in 2021, especially after people find rigorous solutions for the corona pandemic and use more cannabis for recreation and other reasons.
Furthermore, Aphria is the first public licensed, medical cannabis producer which has reported positive cash flow operations with positive earnings in successive quarters.
Tilray (NASDAQ: TLRY)
Tilray is a Canadian pharmaceutical and cannabis company. Tilray (NASDAQ: TLRY) offers growth stocks and the company is expected to grow in sales this year. Investors are expecting improved margins for the company. In Q2 2020, the company’s revenue grew by 10% to $50.4 million which is quite impressive. The company also maintained its gross margin at 26%.
The reason for Tilray’s growth is its reputation as the best cannabis grower in Canada. Because of the quality of its products and the fact that its cannabis is good for recreational use, Tilray has a consistent revenue stream.
Tilray’s exciting growth is also attributed to its growth and distribution of medical marijuana. In the last 36 months, over 40 countries have taken steps to legalize medical marijuana. Furthermore, with countries opening doors to medical marijuana further in 2021, Tilray’s (NASDAQ: TLRY) growth and demand will rise in the coming months.
If you are an investor looking to invest in cannabis stocks or cannabis penny stocks, the three best to invest in 2021 have been listed above.
1 comment
Comments are closed.